Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Banco de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Acta Pharmacol Sin ; 43(10): 2687-2695, 2022 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-35296779

RESUMEN

The small molecule chemical compound cinobufotalin (CB) is reported to be a potential antitumour drug that increases cisplatin (DDP) sensitivity in nasopharyngeal carcinoma. In this study, we first found that CB decreased DDP resistance, migration and invasion in lung adenocarcinoma (LUAD). Mechanistic studies showed that CB induced ENKUR expression by suppressing PI3K/AKT signalling to downregulate c-Jun, a negative transcription factor of ENKUR. Furthermore, ENKUR was shown to function as a tumour suppressor by binding to ß-catenin to decrease c-Jun expression, thus suppressing MYH9 transcription. Interestingly, MYH9 is a binding protein of ENKUR. The Enkurin domain of ENKUR binds to MYH9, and the Myosin_tail of MYH9 binds to ENKUR. Downregulation of MYH9 reduced the recruitment of the deubiquitinase USP7, leading to increased c-Myc ubiquitination and degradation, decreased c-Myc nuclear translocation, and inactivation of epithelial-mesenchymal transition (EMT) signalling, thus attenuating DDP resistance. Our data demonstrated that CB is a promising antitumour drug and may be a candidate chemotherapeutic drug for LUAD patients.


Asunto(s)
Adenocarcinoma del Pulmón , Antineoplásicos , Cisplatino , Neoplasias Nasofaríngeas , Proteínas Adaptadoras Transductoras de Señales , Adenocarcinoma del Pulmón/tratamiento farmacológico , Antineoplásicos/farmacología , Antineoplásicos/uso terapéutico , Bufanólidos , Proteínas de Unión a Calmodulina , Línea Celular Tumoral , Cisplatino/farmacología , Cisplatino/uso terapéutico , Resistencia a Antineoplásicos , Regulación Neoplásica de la Expresión Génica , Humanos , Neoplasias Pulmonares/tratamiento farmacológico , Neoplasias Pulmonares/patología , Cadenas Pesadas de Miosina , Miosinas/metabolismo , Neoplasias Nasofaríngeas/tratamiento farmacológico , Fosfatidilinositol 3-Quinasas/metabolismo , Proteínas Proto-Oncogénicas c-akt/metabolismo , Factores de Transcripción/metabolismo , Peptidasa Específica de Ubiquitina 7 , beta Catenina/metabolismo
2.
Beilstein J Org Chem ; 8: 344-8, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22509203

RESUMEN

A novel and reliable method for the direct preparation of 2,2-dihalo-N-phenylacetamides is reported. The key transformation involves the cleavage of a carbon-carbon bond in the presence of DIB and a Lewis acid as the halogen source, and thus this method significantly expands the value of DIB as a unique and powerful tool in chemical synthesis. This protocol not only adds a new aspect to reactions that use other hypervalent iodine reagents but also provides a wide space for the synthesis of disubstituted acetamides.

3.
Beilstein J Org Chem ; 7: 1436-40, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-22049301

RESUMEN

1-Carbamoyl-2-oxopropyl acetate derivatives were synthesized through an acetoxylation process to methylene with the aid of (diacetoxyiodo)benzene (DIB) as the oxidant. Not only mild reaction conditions, but also excellent yields and good substrate scope make the present protocol potentially useful in organic synthesis.

4.
Acta Crystallogr Sect E Struct Rep Online ; 65(Pt 6): m682, 2009 May 23.
Artículo en Inglés | MEDLINE | ID: mdl-21583041

RESUMEN

In the title complex, [La(C(6)H(4)NO(3))(C(2)O(4))(H(2)O)(2)](n), the La(III) ion is coordinated by eight O atoms from two 2-oxido-pyridinium-3-carboxyl-ate ligands, two oxalate ligands and two water mol-ecules in a distorted bicapped square-anti-prismatic geometry. The carboxyl-ate groups link adjacent La(III) ions, forming two-dimensional layers that are further linked by N-H⋯O and O-H⋯O hydrogen bonds.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA